Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
36
% (year-on-year increase in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Full year1 March 2025–28 February 2026ConsolidatedJapanese GAAPNet Sales61,393¥ millionYear on year +22.1%Progress 93.7%
Operating profit4,914¥ millionYear on year +36.0%Progress 93.6%
Ordinary income4,801¥ millionYear on year +30.0%Progress 93.2%
Net income attributable to owners of the parent4,075¥ millionYear on year +81.0%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥192.61
Operating MarginCurrent fiscal year 8 % / Previous period 7.2 %
Financial position at period-end
Total assets46,806¥ million
of which net assets 19,395 ¥ millionEquity ratio 40.8%vs. prior year-end -17.8pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+2,089
Investment-38
Financials+1,730
Net change+3,781
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥12,801 million
Segment revenueCreative (Japan) ¥39,500 million (YoY +12.2%), Creative (Korea) ¥3,106 million (YoY +0.9%), Medical Field ¥5,782 million (YoY +8.9%), Accounting and legal ¥2,336 million (YoY -4.4%), CRES ¥6,231 million, Other Businesses ¥4,436 million (YoY +6.1%)
Segment profitCreative (Japan) ¥2,890 million (YoY +14.1%), Creative (Korea) ¥-39 million, Medical Field ¥1,437 million (YoY +32.7%), Accounting and legal ¥99 million (YoY -14.2%), CRES ¥643 million, Other Businesses ¥-106 million
Regional salesFiscal year ended February 2026 Japan ¥58,230,923 thousand / South Korea ¥3,106,317 thousand / China ¥39,674 thousand / United States ¥17,022 thousand / Fiscal year ended February 2025 Japan ¥47,103,060 thousand / South Korea ¥3,078,195 thousand / China ¥69,633 thousand / United States ¥24,912 thousand
Outlook and shareholder returns
Full-year earnings forecast
Period Covered1 March 2026 to 28 February 2027
Net Sales¥65,500 million (YoY +6.7%)
Operating profit¥5,250 million (YoY +6.8%)
Ordinary income¥5,150 million (YoY +7.3%)
Profit attributable to owners of the parent¥3,350 million (YoY -17.8%)
Annual Dividend Forecast¥41 → ¥50
Payout ratioFiscal year ended February 2026 26 % / FY2027/2 forecast 31.6 %
Factors Behind Changes in Business Performance
Performance in the core Creative business (Japan) and Healthcare business remained solid, and the 高橋書店 Group also performed well. In South Korea, losses increased due to higher production costs for original comics and other factors, while the impact of longer lead times to close recruitment-service contracts continued in the Accounting and Legal business.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 2 / Name of newly added company 株式会社T&Wオフィス, 株式会社高橋書店 / Excluded 0 / Excluded Company Name Not disclosed / Notes The notes state that 株式会社URS Games and 株式会社T&Wオフィス (高橋書店 Group) were included in the scope of consolidation, while 株式会社プロフェッショナルメディア was excluded.
Material subsequent eventsNot applicable.
Impairment loss¥74,109 thousand
Breakdown of extraordinary income (loss)Extraordinary income Government subsidies ¥619,228 thousand, Settlement proceeds received ¥56,685 thousand, Reversal of provision for directors' retirement benefits ¥6,585 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥11,344 thousand, Loss on sale of investment securities ¥15,195 thousand, Impairment loss on investment securities ¥39,999 thousand, Loss related to office relocation ¥1,186 thousand, Settlement Payments ¥5,128 thousand, Impairment Losses ¥74,109 thousand
Depreciation and amortization¥604,445 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingHeld (対象者：Not disclosed)
Issued Shares at Period-End23,009,000 Shares
Treasury Shares at Period-End1,833,769 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 March 2025–28 February 2026 |
| Net Sales | ¥61,393 million (YoY +22.1%) |
| Operating profit | ¥4,914 million (YoY +36.0%) |
| Ordinary income | ¥4,801 million (YoY +30.0%) |
| Profit attributable to owners of the parent | ¥4,075 million (YoY +81.0%) |
| Net income per share | ¥192.61 |
| Operating Margin | Current fiscal year 8 % / Previous period 7.2 % |
| Equity ratio | End of the current fiscal period 40.8 / End of previous period 58.6 |
| Total assets | ¥46,806 million |
| Net assets | ¥19,395 million |
| Cash flows from operating activities | ¥2,089 million |
| Cash flows from investing activities | ¥-38 million |
| Cash flows from financing activities | ¥1,730 million |
| Cash and cash equivalents at end of period | ¥12,801 million |
| Full-year earnings forecast | Period Covered 1 March 2026 to 28 February 2027 / Net Sales ¥65,500 million (YoY +6.7%) / Operating profit ¥5,250 million (YoY +6.8%) / Ordinary income ¥5,150 million (YoY +7.3%) / Profit attributable to owners of the parent ¥3,350 million (YoY -17.8%) |
| Annual Dividend Forecast | ¥41 → ¥50 |
| Payout ratio | Fiscal year ended February 2026 26 % / FY2027/2 forecast 31.6 % |
| Segment revenue | Creative (Japan) ¥39,500 million (YoY +12.2%), Creative (Korea) ¥3,106 million (YoY +0.9%), Medical Field ¥5,782 million (YoY +8.9%), Accounting and legal ¥2,336 million (YoY -4.4%), CRES ¥6,231 million, Other Businesses ¥4,436 million (YoY +6.1%) |
| Segment profit | Creative (Japan) ¥2,890 million (YoY +14.1%), Creative (Korea) ¥-39 million, Medical Field ¥1,437 million (YoY +32.7%), Accounting and legal ¥99 million (YoY -14.2%), CRES ¥643 million, Other Businesses ¥-106 million |
| Regional sales | Fiscal year ended February 2026 Japan ¥58,230,923 thousand / South Korea ¥3,106,317 thousand / China ¥39,674 thousand / United States ¥17,022 thousand / Fiscal year ended February 2025 Japan ¥47,103,060 thousand / South Korea ¥3,078,195 thousand / China ¥69,633 thousand / United States ¥24,912 thousand |
| Depreciation and amortization | ¥604,445 thousand |
| Impairment loss | ¥74,109 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Government subsidies ¥619,228 thousand, Settlement proceeds received ¥56,685 thousand, Reversal of provision for directors' retirement benefits ¥6,585 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥11,344 thousand, Loss on sale of investment securities ¥15,195 thousand, Impairment loss on investment securities ¥39,999 thousand, Loss related to office relocation ¥1,186 thousand, Settlement Payments ¥5,128 thousand, Impairment Losses ¥74,109 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 2 / Name of newly added company 株式会社T&Wオフィス, 株式会社高橋書店 / Excluded 0 / Excluded Company Name Not disclosed / Notes The notes state that 株式会社URS Games and 株式会社T&Wオフィス (高橋書店 Group) were included in the scope of consolidation, while 株式会社プロフェッショナルメディア was excluded. |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Held (対象者：Not disclosed) |
| Issued Shares at Period-End | 23,009,000 Shares |
| Treasury Shares at Period-End | 1,833,769 Shares |
| Factors Behind Changes in Business Performance | Performance in the core Creative business (Japan) and Healthcare business remained solid, and the 高橋書店 Group also performed well. In South Korea, losses increased due to higher production costs for original comics and other factors, while the impact of longer lead times to close recruitment-service contracts continued in the Accounting and Legal business. |
Items this document does not state (3)
Revision to Earnings ForecastShareholder Return PolicyOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In addition to solid performance in the core Creative business (Japan) and Healthcare business, the 高橋書店 Group, which became a consolidated subsidiary in March 2025, also performed well.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.